BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32041500)

  • 1. Nivolumab efficacy in leptomeningeal metastasis of renal cell carcinoma: a case report.
    Bonomi L; Bettini AC; Arnoldi E; Chirco A; Ghilardi L; Manara O; Roscigno M; Da Pozzo LF; Tondini CA
    Tumori; 2020 Dec; 106(6):NP76-NP78. PubMed ID: 32041500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient.
    Gion M; Remon J; Caramella C; Soria JC; Besse B
    Lung Cancer; 2017 Jun; 108():72-74. PubMed ID: 28625652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.
    Vitale MG; Scagliarini S; Galli L; Pignata S; Lo Re G; Berruti A; Defferrari C; Spada M; Masini C; Santini D; Ciuffreda L; Ruggeri EM; Bengala C; Livi L; Fagnani D; Bonetti A; Giustini L; Hamzaj A; Procopio G; Caserta C; Sabbatini R
    PLoS One; 2018; 13(7):e0199642. PubMed ID: 29979712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma].
    Hattahara K; Yamasaki T; Sawada A; Tanigaki K; Endo S; Teramoto Y; Banno H; Fuchigami Y; Suzuki R; Fujiwara M; Hida T; Yoshino T; Kita Y; Goto T; Akamatsu S; Saito R; Kobayashi T; Inoue T; Ogawa O
    Hinyokika Kiyo; 2019 May; 65(5):157-161. PubMed ID: 31247693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma.
    Ishihara H; Takagi T; Kondo T; Fukuda H; Tachibana H; Yoshida K; Iizuka J; Okumi M; Ishida H; Tanabe K
    In Vivo; 2020; 34(3):1541-1546. PubMed ID: 32354960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Rheumatoid Arthritis Developed during Treatment with Nivolumab for Renal Cell Carcinoma].
    Tomizawa M; Nakai Y; Maesaka F; Owari T; Hara R; Miyake M; Inoue T; Anai S; Tanaka N; Fujimoto K
    Hinyokika Kiyo; 2018 Oct; 64(10):397-401. PubMed ID: 30543737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-Year Lasting Sustained Complete Response After Nivolumab in a Patient With Non-Small-Cell Lung Cancer and Confirmed Leptomeningeal Carcinomatosis: Changing the Paradigm.
    Bover M; Yarza R; Docampo LI
    Clin Lung Cancer; 2020 Jan; 21(1):e1-e5. PubMed ID: 31601524
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
    Brastianos PK; Strickland MR; Lee EQ; Wang N; Cohen JV; Chukwueke U; Forst DA; Eichler A; Overmoyer B; Lin NU; Chen WY; Bardia A; Juric D; Dagogo-Jack I; White MD; Dietrich J; Nayyar N; Kim AE; Alvarez-Breckenridge C; Mahar M; Mora JL; Nahed BV; Jones PS; Shih HA; Gerstner ER; Giobbie-Hurder A; Carter SL; Oh K; Cahill DP; Sullivan RJ
    Nat Commun; 2021 Oct; 12(1):5954. PubMed ID: 34642329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
    De Giorgi U; Cartenì G; Giannarelli D; Basso U; Galli L; Cortesi E; Caserta C; Pignata S; Sabbatini R; Bearz A; Buti S; Lo Re G; Berruti A; Bracarda S; Cognetti F; Rastelli F; Fornarini G; Porta C; Turci D; Sternberg CN; Procopio G;
    BJU Int; 2019 Jan; 123(1):98-105. PubMed ID: 29956884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal hyperprogression induced by nivolumab in metastatic renal cell carcinoma with sarcomatoid features: a case report.
    Dionese M; Pierantoni F; Maruzzo M; Bimbatti D; Deppieri FM; Maran M; Gardiman MP; Basso U
    Anticancer Drugs; 2021 Feb; 32(2):222-225. PubMed ID: 32868643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dramatic response to nivolumab after local radiotherapy in pulmonary pleomorphic carcinoma with rapid progressive post-surgical recurrence.
    Yaguchi D; Ichikawa M; Ito M; Okamoto S; Kimura H; Watanabe K
    Thorac Cancer; 2019 May; 10(5):1263-1266. PubMed ID: 30860657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma.
    José JM; Jose M; Silverio R; Federico V; Isabel C; Martin OA; Inmaculada B; Cristina C; Julia HC; Dolores TM; Jose G; Paola P; Nieves DP; Vicent A; Sara B; Sara M; Julián L; Manuel S; Del Carmen MM; Ángel CM; Vicente G
    Clin Transl Oncol; 2020 Sep; 22(9):1517-1523. PubMed ID: 32048159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of metastatic clear cell carcinoma with nivolumab in a patient receiving dialysis treatment.
    Tabei T; Natsume I; Kobayashi K
    Int J Urol; 2017 Sep; 24(9):708-710. PubMed ID: 28734029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid development of an atypical meningioma during Nivolumab therapy for metastatic renal cell carcinoma.
    Abele N; Luchtmann M; Donitza A; Janitzky A; Sandalcioglu IE; Skalej M; Schostak M; Reifenberger G; Mawrin C
    Clin Neurol Neurosurg; 2020 Aug; 195():105938. PubMed ID: 32502948
    [No Abstract]   [Full Text] [Related]  

  • 15. Leptomeningeal carcinomatosis from squamous cell carcinoma of the supraglottic larynx.
    Thompson SR; Veness MJ; Morgan GJ; Shannon J; Kench JG
    Australas Radiol; 2003 Sep; 47(3):325-30. PubMed ID: 12890260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases.
    Dudnik E; Yust-Katz S; Nechushtan H; Goldstein DA; Zer A; Flex D; Siegal T; Peled N
    Lung Cancer; 2016 Aug; 98():114-117. PubMed ID: 27393516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Nivolumab-Induced Isolated Adrenocorticotropic Hormone Deficiency Presenting Dyspnea].
    Ito K; Uchida T; Manabe Y; Miyazaki Y; Itoh H; Mishina M; Okuno H
    Hinyokika Kiyo; 2018 Oct; 64(10):391-395. PubMed ID: 30543736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report.
    Naito T; Umemura S; Nakamura H; Zenke Y; Udagawa H; Kirita K; Matsumoto S; Yoh K; Niho S; Motoi N; Aokage K; Tsuboi M; Ishii G; Goto K
    Thorac Cancer; 2019 May; 10(5):1285-1288. PubMed ID: 30972962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of nivolumab for the treatment of metastatic renal cell carcinoma.
    Zarrabi K; Wu S
    Expert Opin Biol Ther; 2018 Jun; 18(6):695-705. PubMed ID: 29782188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal fulminant hepatitis induced by combined ipilimumab and nivolumab therapy despite favorable histologic response and confirmed by autopsy in a patient with clear cell renal cell carcinoma.
    Kubo T; Sugawara T; Shinkawa T; Kurisu T; Kouzen N; Tanaka T; Fukuta F; Yamasaki K; Sugita S; Matsuo K; Morita R; Hirohashi Y; Tsukahara T; Kanaseki T; Hasegawa T; Masumori N; Torigoe T
    Immunol Med; 2021 Jun; 44(2):136-141. PubMed ID: 32634346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.